Cappello Joseph 4
4 · GENELUX Corp · Filed Dec 11, 2025
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Cappello Joseph
VP, Pharmaceutical Development
Transactions
- Sale
Common Stock
2025-08-21$3.33/sh−1,270$4,225→ 158,496 total - Sale
Common Stock
2025-08-21$3.36/sh−1,463$4,912→ 157,033 total - Sale
Common Stock
2025-11-17$5.37/sh−973$5,224→ 156,060 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.
- [F2]The total shown in Column 5 takes into account the transactions reported on Form 4 filed on August 29, 2025.